25-28 June 2014

Barcelona, Spain


Thank you for attending the premier annual event in gastrointestinal cancer!

Thank you for attending the ESMO 16th World Congress on Gastrointestinal Cancer. Our 16th year of the largest Congress specifically designed for practicing clinicians, gastroenterologists, hepatologists, surgeons, medical oncologists, radiation oncologists, and clinical researchers who wish to review and update their knowledge and management of cancers of the gastrointestinal tract was a great success.

We’d like to extend our sincere gratitude to all the attendees, faculty, staff, and supporters that helped make this such a wonderful experience.

Over the next few days and weeks, we'll be sending out emails with the conference presentations, links for accreditation, a webcast, and a faculty survey. Your feedback is extremely valuable to us, and we appreciate your participation. Additionally, if you have any questions regarding CME certificates, Certificates of Attendance, or any general inquiry, please contact us via email at meetings@imedex.com or via phone +1 (800) 233-0957.

Our 17th year will take place 1 - 4 July 2015 in beautiful Barcelona, Spain. Mark your calendars! We look forward to seeing all of you again next year. 

Congress Chairs

Mario Dicato, MD
Mario Dicato, MD

Luxembourg, Luxembourg

Eric Van Cutsem, MD, PhD
Eric Van Cutsem, MD, PhD
Leuven, Belgium

Josep Tabernero, MD, PhD
Josep Tabernero, MD, PhD

Barcelona, Spain
Vice Chair

Coverage from our 16th Congress

Ramucirumab Benefit for US Patients With Gastric Cancer Mirrors Global Results

Regorafenib Offers Effective Option for Asian Patients With mCRC

Ruxolitinib Combo Improves Outcomes in Metastatic Pancreatic Cancer

Prognostic Scale Developed for Overall Survival in Locally Advanced Pancreatic Cancer

Dr. Chris Cunningham discusses the question if all patients with gastric cancer should be treated with adjuvant and/or neoadjuvant treatment at 16th Annual World GI Congress

Interview with Dr. Han van Krieken: European experience in RAS testing

Cetuximab does not improve chemoradiation therapy in esophageal cancer

RAINBOW establishes the advantages of ramucirunab in gastric cancer


Congress Endorsers

The Cholangiocarcinoma Foundation

European Neuroendocrine Tumor Society (ENETS)

European Oncology Nursing Society (EONS)

European Oncology Nursing Society (EONS)

EORTC Gastrointestinal Tumour Group






11675 Rainwater Drive, Suite 600
Alpharetta, GA 30009, USA
Tel.: +1 (770) 751 7332
Fax: +1 (770) 751 7334
Email: meetings@imedex.com
Twitter: twitter.com/ImedexCME
Facebook: facebook.com/Imedex
Web: www.imedex.com

For registration inquiries:
Tel.: +1 (678) 242-0906
Toll-free (USA only): +1 (800) 233-0957
Fax: +1 (770) 751-7334
Email: registration@imedex.com